# OnCo record nuvox-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/nuvox-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "nuvox-therapeutics" ;
  schema:name "NuvOx Therapeutics"@en ;
  schema:alternateName "NuvOx Therapeutics, Inc."@en, "NuvOx LLC"@en ;
  schema:description "NuvOx Therapeutics is an Arizona company developing NanO2, an infusion that carries extra oxygen into tissues. In cancer it is being tested to make radiotherapy work better against glioblastoma, a brain tumour that is often short of oxygen."@en ;
  schema:url <https://onco.cc/companies/nuvox-therapeutics/>, <https://www.nuvoxtherapeutics.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.sec.gov/Archives/edgar/data/1966126/000121390026113463/ea0225257-14.htm>, <https://www.nuvoxtherapeutics.com/> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/radiation/> ;
  onco:technologies <https://onco.cc/technologies/radiosensitisers/>, <https://onco.cc/technologies/tumour-hypoxia-modification/> ;
  onco:drugs <https://onco.cc/drugs/nano2/> .